(Q42478364)

1 November 2017

title

Study of a new PPARgamma2 promoter polymorphism and haplotype analysis in a French population (English)

1 reference

1 November 2017

7

Johan Auwerx

1 reference

1 November 2017

Aline Meirhaeghe

1

0 references

Philippe Amouyel

object named as

Philippe Amouyel

8

0 references

Jean Dallongeville

9

object named as

Jean Dallongeville

1 reference

1 November 2017

Michael W T Tanck

2

1 reference

1 November 2017

Lluis Fajas

3

1 reference

1 November 2017

Caroline Janot

4

1 reference

1 November 2017

Nicole Helbecque

5

1 reference

1 November 2017

Dominique Cottel

6

1 reference

1 November 2017

publication date

1 June 2005

1 reference

Molecular Genetics and Metabolism

1 November 2017

published in

1 reference

1 November 2017

volume

85

1 reference

1 November 2017

issue

2

1 reference

1 November 2017

page(s)

140-148

1 reference

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Metabolic and additional vascular effects of thiazolidinediones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Terminal differentiation of human breast cancer through PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Peroxisome proliferator-activated receptor gamma induces growth arrest and differentiation markers of human colon cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

PPAR(gamma) and glucose homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

The organization, promoter analysis, and expression of the human PPARgamma gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Identification of a novel peroxisome proliferator-activated receptor (PPAR) gamma promoter in man and transactivation by the nuclear receptor RORalpha1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A functional polymorphism in a STAT5B site of the human PPAR gamma 3 gene promoter affects height and lipid metabolism in a French population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Ecological analysis of the association between mortality and major risk factors of cardiovascular disease. The World Health Organization MONICA Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Determinants of GATA-1 binding to DNA: the role of non-finger residues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein gene locus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Function of GATA transcription factors in preadipocyte-adipocyte transition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

GATA transcription factors and fat cell formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

A road map for those who don't know JAK-STAT

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

The proline 12 alanine substitution in the peroxisome proliferator--activated receptor-gamma2 gene is associated with lower lipoprotein lipase activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

Impact of genetic variation of PPARgamma in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2005.02.004

10.1016/J.YMGME.2005.02.004

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference